Rituxan rituximab: Marketed

Data from 10 of the 18 patients enrolled in an ongoing 40-patient pilot study showed that the combination of Rituxan and fludarabine chemotherapy gave 6 complete remissions, 1 partial remission, and 3 withdrawals due to hematologic or pulmonary toxicity. ...